[1] Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends[J]. Theranostics, 2013, 3(6): 377394. DOI: 10.7150/thno.5195.
[2] Ashworth TR. A case of cancer in which cells similar to those in tumors were seen in the blood after death[J]. Aust Med, 1869, 14: 146149.
[3] Yagi S, Koh Y, Akamatsu H, et al. Development of an automated sizebased filtration system for isolation of circulating tumor cells in lung cancer patients[J]. PLoS One, 2017, 12(6): e0179744. DOI: 10.1371/journal. pone.0179744.
[4] Reyes EE, Gillard M, Duggan R, et al. Molecular analysis of CD133positive circulating tumor cells from patients with metastatic castrationresistant prostate cancer[J]. J Transl Sci, 2015, 1(1): pii: http://oatext.com/MolecularanalysisofCD133positivecirculatingtumorcellsfrompatientswithmetastaticcastrationresistantprostatecancer.php.
[5] 黄文涛. 胆道肿瘤循环肿瘤细胞的检测及基因组扩增[D] . 福州: 福建医科大学, 2015.
[6] Wong VC, Ko JM, Lam C. Succinct workflows for circulating tumor cells after enrichment: from systematic counting to mutational profiling[J]. PLoS One, 2017, 12(5): e0177276. DOI: 10.1371/journal.pone.0177276.
[7] 苏喜. 新型磁性碳量子点设计制备及其用于CTC检测研究[D] . 重庆: 重庆大学, 2015.
[8] Gonzales PR, Mikhail FM. Diagnostic and prognostic utility of fluorescence in situ hybridization (FISH) analysis in acute myeloid leukemia[J]. Curr Hematol Malig Rep, 2017, 12(6): 568573. DOI: 10.1007/s11899 01704266.
[9] Swennenhuis JF, Tibbe AG, Levink R, et al. Characterization of circulating tumor cells by fluorescence in situ hybridization[J]. Cytometry A, 2009, 75(6): 520527. DOI: 10.1002/cyto.a.20718.
[10] 张玉娟. 循环肿瘤细胞检测的方法学建立和改良及在实体瘤中的监测应用研究[D] . 北京: 北京协和医学院, 2014.
[11] 张浩强, 李明辉, 王臻, 等. 免疫荧光联合原位杂交技术检测骨肉瘤患者外周血中循环肿瘤细胞的表达及临床意义[J]. 中华肿瘤杂志, 2017, 39(7): 485489. DOI: 10.3760/cma.j.issn.02533766.2017.07.002.
[12] Liu H, Sun B, Wang S, et al. Circulating tumor cells as a biomarker in pancreatic ductal adenocarcinoma[J]. Cell Physiol Biochem, 2017, 42(1): 373382. DOI: 10.1159/000477481.
[13] Wu W, Zhang Z, Gao XH, et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostainingfluorescence in situ hybridization (SEiFISH)[J]. Oncotarget, 2017, 8(13): 2163921649. DOI: 10.18632/oncotarget.15452.
[14] Zhang HQ, Gao P, Xiao X, et al. A liquid biopsybased method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients[J]. Int J Oncol, 2017, 50(4): 10751086. DOI: 10.3892/ijo.2017.3905.
[15] Xu Y, Qin T, Li J, et al. Detection of circulating tumor cells using negative enrichment immunofluorescence and an in situ hybridization system in pancreatic cancer[J]. Int J Mol Sci, 2017, 18(4): 10. DOI: 10.3390/ijms18040622.
[16] Frithiof H, Aaltonen K, Rydén L, et al. A FISHbased method for assessment of HER2 amplification status in breast cancer circulating tumor cells following CellSearch isolation[J]. Onco Targets Ther, 2016, 9: 70957103. DOI:10.2147/OTT.S118502.
[17] Leversha MA, Han J, Asgari Z, et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer[J]. Clin Cancer Res, 2009, 15(6): 20912097. DOI: 10.1158/10780432.CCR082036.
[18] 刘勇. 双光子细胞膜和核糖核酸探针的合成及其在活细胞荧光成像中的应用[D] . 济南: 山东大学, 2014.
[19] Kojima T, Hashimoto Y, Watanabe Y, et al. A simple biological imaging system for detecting viable human circulating tumor cells[J]. J Clin Invest, 2009, 119(10): 31723181. DOI: 10.1172/JCI38609.
[20] Satelli A, Mitra A, Cutrera JJ, et al. Universal marker and detection tool for human sarcoma circulating tumor cells[J]. Cancer Res, 2014, 74(6): 16451650. DOI: 10.1158/00085472.CAN131739.
[21] 方帅. 上转换纳米探针在循环肿瘤细胞的富集和检测中的应用[D] . 苏州: 苏州大学, 2014.
[22] 贾真珍. 循环肿瘤细胞的捕获及胞内雌激素受体检测探针的设计与合成[D] . 济南: 山东师范大学, 2015.
[23] Hwang JY, Kim ST, Han HS, et al. Optical aptamer probes of fluorescent imaging to rapid monitoring of circulating tumor cell[J]. Sensors (Basel), 2016, 16(11): E1909. DOI: 10.3390/s16111909.
[24] 张鹏. 血液中循环肿瘤细胞的捕集与SER成像检测其相关蛋白质组学研究新技术的开发[D] . 上海: 复旦大学, 2014. |